摘要
目的：探讨扶正抑癌汤在大肠癌术后巩固治疗中的临床价值。方法：对３８例大肠癌术后患者采用扶正抑癌汤加化疗治疗（治疗组），并与３１例单纯化疗（对照组）进行对照。结果：治疗组患者体力状况好于对照组（Ｐ＜００１），中位生存时间（３１４个月）长于对照组（１８０个月）；治疗组生存率高于对照组（Ｐ＜００５），毒副反应发生率低于对照组（Ｐ＜００５或Ｐ＜００１）；治疗组复发率（２１０５％）低于对照组（４８３４％，Ｐ＜００５）；治疗组治疗后免疫功能改善（Ｐ＜００５或Ｐ＜００１）。结论：扶正抑癌汤配合化疗在大肠癌术后巩固治疗中，其免疫调节、抑癌抗复发、延长生存周期等作用优于单纯化疗。
Objective: To investigate the clinical value of Fuzheng Yiai Decoction (FZYAD) in postoperational large intestinal Cancer after treatment. Methods: Thirty eight cases treated by FZYAD combined with chemotherapy in the treated group were observed and compared with 30 patients in the control group treated with chemotherapy alone. Results: After treatment, patients′ physical strength of the treated group was better than that of the control group (P<0 01), meanwhile, the median survival time was longer (31.4 months vs 18 months, P<0 01), the survival rate higher (P<0 05), and the recurrence rate lower (21.05% vs 48.34%, P<0 05) in comparison of the treated group and the control group. Moreover, the cellular immune function of the treated group was improved after treatment. Conclusions: In treatment of postoperational large intestinal cancer, the effect of FZYAD combined chemotherapy is better than that of chemotherapy alone in immune function regulation, cancer inhibition, relapse prevention and survival time prolongation.
出处
《中国中西医结合杂志》
CAS
CSCD
北大核心
1999年第1期20-22,共3页
Chinese Journal of Integrated Traditional and Western Medicine
关键词
大肠癌
扶正抑癌汤
中西医结合治疗
postoperational large intestinal cancer, therapy of traditional Chinese Medicine, chemotherapy, Fuzheng Yiai Decoction
